Blue Owl Capital (NYSE:OWL) Earns Overweight Rating from Analysts at Barclays

Investment analysts at Barclays began coverage on shares of Blue Owl Capital (NYSE:OWL) in a research note issued on Monday,Briefing.com Automated Import reports. The firm set an “overweight” rating and a $29.00 price target on the stock. Barclays‘s price target would suggest a potential upside of 31.36% from the stock’s previous close.

OWL has been the subject of several other reports. Citigroup reiterated a “buy” rating and set a $30.00 price target on shares of Blue Owl Capital in a research report on Thursday, January 23rd. Evercore ISI upped their price target on Blue Owl Capital from $25.00 to $26.00 and gave the stock an “outperform” rating in a research note on Friday, January 17th. Oppenheimer boosted their price target on shares of Blue Owl Capital from $24.00 to $28.00 and gave the stock an “outperform” rating in a research note on Thursday, December 12th. JMP Securities reiterated a “market outperform” rating and issued a $32.00 price target (up previously from $30.00) on shares of Blue Owl Capital in a research note on Friday, February 7th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Blue Owl Capital from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Friday, November 1st. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.48.

Blue Owl Capital Price Performance

Shares of NYSE OWL opened at $22.08 on Monday. The business has a fifty day moving average price of $24.01 and a 200 day moving average price of $21.84. Blue Owl Capital has a 1-year low of $15.18 and a 1-year high of $26.73. The stock has a market capitalization of $32.97 billion, a P/E ratio of 129.87, a price-to-earnings-growth ratio of 1.23 and a beta of 1.15.

Blue Owl Capital (NYSE:OWL) last announced its quarterly earnings data on Thursday, February 6th. The company reported $0.21 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.21. Blue Owl Capital had a return on equity of 20.82% and a net margin of 4.77%. As a group, equities research analysts anticipate that Blue Owl Capital will post 0.92 earnings per share for the current fiscal year.

Institutional Trading of Blue Owl Capital

Several hedge funds and other institutional investors have recently modified their holdings of OWL. FMR LLC lifted its holdings in Blue Owl Capital by 28.1% in the 4th quarter. FMR LLC now owns 45,241,160 shares of the company’s stock worth $1,052,309,000 after purchasing an additional 9,917,071 shares during the last quarter. Capital World Investors grew its holdings in shares of Blue Owl Capital by 14.5% during the 4th quarter. Capital World Investors now owns 77,168,640 shares of the company’s stock worth $1,794,943,000 after purchasing an additional 9,794,102 shares in the last quarter. Cresset Asset Management LLC increased its holdings in Blue Owl Capital by 4,278.0% in the 4th quarter. Cresset Asset Management LLC now owns 6,053,065 shares of the company’s stock valued at $140,794,000 after buying an additional 5,914,804 shares during the period. Norges Bank acquired a new position in Blue Owl Capital in the fourth quarter worth about $137,118,000. Finally, Vanguard Group Inc. lifted its position in shares of Blue Owl Capital by 11.7% during the 4th quarter. Vanguard Group Inc. now owns 53,206,392 shares of the company’s stock worth $1,237,581,000 after buying an additional 5,558,868 shares during the period. 35.85% of the stock is currently owned by hedge funds and other institutional investors.

Blue Owl Capital Company Profile

Blue Owl Capital Inc operates as an asset manager in the United States. The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants.